Adalta Ltd - Asset Resilience Ratio

Latest as of June 2024: -3.70%

Adalta Ltd (1AD) has an Asset Resilience Ratio of -3.70% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Adalta Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$-206.28K

≈ $-145.96K USD Cash + Short-term Investments

Total Assets

AU$5.57 Million

≈ $3.94 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2024)

This chart shows how Adalta Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 1AD asset base.

Liquid Assets Composition Over Time

This chart breaks down Adalta Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 1AD strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$-206.28K	-3.7%
Total Liquid Assets	AU$-206.28K	-3.70%

Asset Resilience Insights

Limited Liquidity: Adalta Ltd maintains only -3.70% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Adalta Ltd Industry Peers by Asset Resilience Ratio

Compare Adalta Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Abivax SA PA:ABVX	Biotechnology	2.58%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Lifecome Biochemistry Co Ltd SHE:002868	Biotechnology	4.69%
Pulike Biological Engineering SHG:603566	Biotechnology	17.82%
Rocket Pharmaceuticals Inc NASDAQ:RCKT	Biotechnology	14.00%
NEWRON PHARMACEUT. EO-20 XETRA:NP5	Biotechnology	41.67%
Upstream Bio, Inc. NASDAQ:UPB	Biotechnology	64.70%

Annual Asset Resilience Ratio for Adalta Ltd (2017–2024)

The table below shows the annual Asset Resilience Ratio data for Adalta Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-06-30	-3.70%	AU$-206.28K ≈ $-145.96K	AU$5.57 Million ≈ $3.94 Million	-52.44pp
2020-06-30	48.74%	AU$3.37 Million ≈ $2.38 Million	AU$6.91 Million ≈ $4.89 Million	-10.94pp
2019-06-30	59.68%	AU$5.56 Million ≈ $3.93 Million	AU$9.31 Million ≈ $6.59 Million	+7.73pp
2018-06-30	51.95%	AU$2.31 Million ≈ $1.63 Million	AU$4.44 Million ≈ $3.14 Million	-24.99pp
2017-06-30	76.94%	AU$6.22 Million ≈ $4.40 Million	AU$8.09 Million ≈ $5.72 Million	--

pp = percentage points

About Adalta Ltd

AU:1AD Australia Biotechnology

Market Cap

$6.31 Million

AU$8.92 Million AUD

Market Cap Rank

#28213 Global

#1458 in Australia

Share Price

AU$0.00

Change (1 day)

+0.00%

52-Week Range

AU$0.00 - AU$0.01

All Time High

AU$0.37